Perrigo Company plc (PRGO) Financials

PRGO Assets vs Liabilities

DateAssetsLiabilities
March 31, 2024 10.6 billion 6.0 billion
Dec. 31, 2023 10.8 billion 6.0 billion
Sept. 30, 2023 10.8 billion 6.0 billion
June 30, 2023 11.0 billion 6.1 billion

PRGO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
March 31, 2024 -26.5 million 15.6 million
Dec. 31, 2023 182.0 million 10.6 million
Sept. 30, 2023 92.7 million 14.7 million
June 30, 2023 32.9 million 18.6 million

PRGO Net Income

No data available :(

PRGO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
March 31, 2024 658.5 million - -
Dec. 31, 2023 751.3 million - -
Sept. 30, 2023 598.3 million - 173.0 million
June 30, 2023 555.2 million 4.1 billion 180.3 million

PRGO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
March 31, 2024 137.6 million
Dec. 31, 2023 135.5 million
Sept. 30, 2023 136.9 million
June 30, 2023 136.6 million

PRGO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
March 31, 2024 25.1 million 29.0 million 130.4 million 175.2 million
Dec. 31, 2023 26.7 million 29.6 million 128.7 million 178.1 million
Sept. 30, 2023 31.8 million 29.6 million 126.0 million 178.0 million
June 30, 2023 20.0 million 32.2 million 132.6 million 199.7 million

PRGO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
March 31, 2024 1.1 billion 724.2 million
Dec. 31, 2023 1.2 billion 729.6 million
Sept. 30, 2023 1.1 billion 712.6 million
June 30, 2023 1.2 billion 765.1 million

PRGO

List: Contenders

Price: $25.78

52 week price:
25.55
40.28

Dividend Yield: 0.04%

5-year range yield:
0.04%
4.19%

Forward Dividend Yield: 4.28%

Payout Ratio: 11040.00%

Payout Ratio Range:
-3680.00%
11040.00%

Dividend Per Share: 1.10 USD

Earnings Per Share: 0.01 USD

P/E Ratio: 2694

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 680000

Ebitda: 274.7 million

Market Capitalization: 3.7 billion

Average Dividend Frequency: 4

Years Paying Dividends: 22

DGR3: 9.60%

DGR5: 10.35%

DGR10: 12.61%

Links: